Welcome to intervention Wednesday. The Bank of England has halted, at least for now, soaring gilt yields via some temporary bond buying. Stock futures pared some losses, but are still Read more
Tag: Healthcare
Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
Next stop regulatory approval. That was the view of analysts at Mizuho Securities, who late Tuesday lifted shares of Biogen Inc. BIIB, +1.04% to buy from neutral after the pharmaceutical Read more
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and Biogen Inc. said their experimental Alzheimer’s disease drug significantly slowed progression of the disease in Read more
Alzheimer’s drug from Eisai, Biogen shows promise in large trial
Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug significantly slowed progression of the memory-robbing disease in a large study, bolstering the drug’s prospects for approval. The pharmaceutical companies Read more
Opinion: Feeding people on this warming Earth requires future-proofing our agri-food systems. Here’s how.
These days, it is easy to feel overwhelmed. A worsening regional conflict in Ukraine, overlain onto a lingering pandemic, threatens a cascading humanitarian crisis across continents. The latest climate science confirms that we are now Read more
Melt Pharmaceuticals files for IPO
Melt Pharmaceuticals, Inc. filed for an initial public offering with the Securities and Exchange Commission on Wednesday. The company said it is focused on developing and commercializing “proprietary non-opioid, non-IV, Read more
FDA warns ‘NyQuil chicken’ is ‘a recipe for danger’
What the actual cluck? The latest seriously questionable social-media trend apparently has people sautéing chicken in over-the-counter cough and cold medicine like NyQuil, presumably to eat. And this “NyQuil chicken,” Read more
Judge denies DOJ’s request to block UnitedHealth’s acquisition of Change Healthcare
WASHINGTON — A federal judge Monday ruled against a Justice Department antitrust challenge to UnitedHealth Group Inc.’s UNH, +0.49% $13 billion acquisition of health-technology firm Change Healthcare Inc. CHNG, -0.08%, rejecting government claims that the deal Read more
Roche’s vision-loss drug Vabysmo gets EU nod
Roche Holding AG said Monday that its vision-loss treatment Vabysmo has been approved in the European Union after successful phase-3 study data. Vabysmo (faricimab) is a treatment for age-related macular Read more
Market rout casts cloud over biggest IPO of the year as at least two deals are pulled during brutal selloff
At least two initial public offerings were withdrawn during Tuesday’s brutal stock market rout, casting a shadow over what’s expected to be the year’s biggest deal, the $1.8 billon offering Read more